Life Sciences
China
Contribution fromKing & Wood Mallesons
Life sciences and healthcare: PRC firms
FOCUS ON…
By Fangda Partners — 1. Introduction Since the end of 2023, the mergers and acquisitions (M&A) trend in China’s life sciences industry has garnered substantial interest. This trend was, notably, initiated by AstraZeneca’Read more
- 1Firm profileFangda Partners
- 1Firm profileGlobal Law Office
- 1Firm profileKing & Wood MallesonsClient satisfaction
- 1Firm profileZhong Lun Law Firm
- 3Firm profileAnJie Broad Law Firm
- 3Firm profileDacheng
- 3Firm profileFenXun Partners
- 3Firm profileJingtian & GongchengClient satisfaction
- 3Firm profileLlinks Law Offices
- 3Firm profileShihui Partners
- 3Firm profileTian Yuan Law FirmClient satisfaction
- 3DaHui Lawyers
- 4Firm profileAllBright Law Offices
- 4Firm profileCommerce & Finance Law Offices
- 4Firm profileJincheng Tongda & Neal
- 4ZSK Attorneys-at-Law
